ABOUT US
WHAT WE DO
INVESTORS
CONTACT US
Back
ABOUT PCI BIOTECH
BOARD OF DIRECTORS
MANAGEMENT
COMPANY PRESENTATION
Back
TECHNOLOGY
PIPELINE
PARTNERING
Back
INVESTORS
NEWS
REPORTS AND PRESENTATIONS
SHARE INFORMATION
GENERAL MEETING INFORMATION
FINANCIAL CALENDAR
CORPORATE GOVERNANCE AND CSR
NOMINATION COMMITTEE
ABOUT US
ABOUT PCI BIOTECH
BOARD OF DIRECTORS
MANAGEMENT
COMPANY PRESENTATION
WHAT WE DO
TECHNOLOGY
PIPELINE
PARTNERING
INVESTORS
INVESTORS
NEWS
REPORTS AND PRESENTATIONS
SHARE INFORMATION
GENERAL MEETING INFORMATION
FINANCIAL CALENDAR
CORPORATE GOVERNANCE AND CSR
NOMINATION COMMITTEE
CONTACT US
NEWS
News archive
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Employee share option scheme
Ronny Skuggedal
November 25, 2022
PCI Biotech interim Q3 2022 results
Ronny Skuggedal
November 23, 2022
Invitation to Q3 2022 results presentation
Ronny Skuggedal
November 17, 2022
PCI Biotech interim first-half year 2022 results
Guest User
August 31, 2022
PCI Biotech: Invitation to first-half year 2022 results presentation
Guest User
August 29, 2022
PCI Biotech: Company update
Guest User
August 18, 2022
Minutes from Annual General Meeting 2022
Guest User
May 25, 2022
PCI Biotech is seeking a Financial Manager
Guest User
May 11, 2022
PCI Biotech interim first quarter 2022 results
Guest User
May 11, 2022
PCI Biotech to present at TIDES USA 2022
Guest User
May 9, 2022
PCI Biotech: Invitation to Q1 2022 results presentation
Guest User
May 4, 2022
Notice of Annual General Meeting 2022
Guest User
May 4, 2022
PCI Biotech Holding ASA publishes the Annual Report 2021
Guest User
April 28, 2022
PCI Biotech CEO resigns to assume new position
Guest User
March 28, 2022
PCI Biotech fourth quarter and preliminary full year 2021 results
Guest User
February 18, 2022
PCI Biotech: Invitation to Q4 2021 result presentation
Guest User
February 14, 2022
PCI Biotech: Update on the RELEASE trial
Guest User
January 24, 2022
PCI Biotech: Publication of preclinical tuberculosis results
Guest User
January 11, 2022
PCI Biotech and MDimune announce research collaboration agreement
Guest User
January 5, 2022
